Lal et al., 2000 - Google Patents
Analysis of Genetic Variability within theLal et al., 2000
View PDF- Document ID
- 3686095259365318093
- Author
- Lal R
- Nkengasong D
- Rayfield M
- Hu D
- Publication year
- Publication venue
- J. Clin. Microbiol
External Links
Snippet
MATERIALS AND METHODS Study subjects. Samples tested in the present study are part of various ongoing studies throughout the world and were selected based on their HIV-1- positive results with various EIA kits. Plasma specimens from 247 HIV-1 group M-infected …
- 238000004458 analytical method 0 title description 17
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—AIDS or HTLV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2009213045B2 (en) | Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens | |
| Gorny et al. | Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades | |
| Xu et al. | Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies | |
| US6265200B1 (en) | HIV-3 retrovirus and its use | |
| Zolla-Pazner et al. | Serotyping of primary human immunodeficiency virus type 1 isolates from diverse geographic locations by flow cytometry | |
| JPH07309779A (en) | Production of envelop antigen for virus of lymphadenopathy and acquired immunodeficiency, and use of the antigen for preparing immunogen composition or detecting antibody for the virus | |
| Dorn et al. | Analysis of genetic variability within the immunodominant epitopes of envelope gp41 from human immunodeficiency virus type 1 (HIV-1) group M and its impact on HIV-1 antibody detection | |
| US6074646A (en) | Nondenatured HIV envelope antigens for detecting early HIV-specific antibodies | |
| Robertson et al. | Maternal antibodies to gp120 V3 sequence do not correlate with protection against vertical transmission of human immunodeficiency virus | |
| Zwart et al. | Greater diversity of the HIV-1 V3 neutralization domain in Tanzania compared with The Netherlands: serological and genetic analysis | |
| WO1998023771A9 (en) | A new eia test using non-dentured hiv antigen for early detection of hiv infection | |
| Kanki et al. | Virology of HIV-1 and HIV-2: implications for Africa | |
| Alcaro et al. | Synthetic peptides in the diagnosis of HIV infection | |
| KR19990022114A (en) | Diagnosis and vaccination of positive strand RNA viruses using extracted, untreated polypeptides | |
| Porter et al. | Genetic, antigenic and serologic characterization of human immunodeficiency virus type 1 from Indonesia | |
| BAILLOU et al. | High antigenic cross-reactivity of the V3 consensus sequences of HIV-1 gp120 | |
| Warren et al. | Synthetic peptides define the fine specificity of the human immunodeficiency virus (HIV) gp160 humoral immune response in HIV type 1-infected chimpanzees | |
| Lal et al. | Analysis of Genetic Variability within the | |
| Mohabatkar et al. | Prediction of exposed domains of envelope glycoprotein in Indian HIV-1 isolates and experimental confirmation of their immunogenicity in humans | |
| Norrby et al. | Immunochemistry of the dominating antigenic region Ala582 to Cys604 in the transmembranous protein of simian and human immunodeficiency virus. | |
| JOHNSON et al. | Site-directed ELISA identifies a highly antigenic region of the simian immunodeficiency virus transmembrane glycoprotein | |
| WO1992022572A1 (en) | New hiv-1 gag and env peptides, diagnostic | |
| Hewer et al. | Envelope-based HIV vaccine peptides as antigens in HIV-1 immunodiagnostics | |
| AU780017B2 (en) | Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens | |
| Norrby | Human immunodeficiency virus antibody responses determined by site-directed serology |